On this page
Congenital insensitivity to pain (SCN11A)
This extremely rare neurogenetic disorder causes absence of pain sensation from birth, leading to injuries and complications that typically go unnoticed. Caused by pathogenic variants in the SCN11A gene, the condition follows an autosomal dominant inheritance pattern and requires lifelong vigilance to prevent accidental harm.
Overview
Congenital insensitivity to pain associated with SCN11A variants is an exceptionally rare neurological condition characterised by the complete inability to perceive pain from birth. Affected individuals do not experience the normal warning signals that pain provides, meaning injuries, burns, fractures, and other tissue damage occur without the person being aware. This absence of protective pain responses creates significant safety challenges throughout life.
The condition results from pathogenic changes in the SCN11A gene, which provides instructions for building a sodium channel protein essential for transmitting pain signals in sensory nerve cells. Unlike acquired pain insensitivity from nerve damage or medication, this form is present from the earliest stages of life and remains constant. The extreme rarity of this condition means exact prevalence figures are not well established, though fewer than a handful of families have been documented worldwide with this specific genetic cause.
Symptoms & clinical features
The hallmark feature is complete absence of pain perception across all situations where pain would normally occur. Infants may not cry when injured, and children often sustain burns, cuts, fractures, and dental problems without complaint. Self-inflicted injuries are common in early childhood as affected individuals lack the normal feedback that prevents tissue damage. Tongue and lip biting may occur, and bone fractures can go unrecognised until deformity develops.
Beyond pain insensitivity, some affected individuals retain normal sensation of touch, temperature, and pressure, though the specific sensory profile can vary. Importantly, cognitive development and other neurological functions typically remain unaffected. The condition does not impair intelligence or motor abilities, but the lack of pain sensation leads to behavioural adaptations as individuals learn through other means which activities cause harm.
Video: Genetics 101
Affected organs
The primary affected system is the peripheral nervous system, specifically the sensory nerve fibres responsible for detecting and transmitting pain signals to the brain and spinal cord. The SCN11A protein is expressed in dorsal root ganglion neurons and trigeminal ganglion neurons, which carry pain information from the body and face respectively.
Secondary complications affect multiple organ systems due to unrecognised injury. The musculoskeletal system frequently sustains fractures, joint damage, and bone infections. Skin may show chronic wounds, burns, and scarring. Dental structures often deteriorate from unnoticed grinding or biting. Internal organs can develop serious complications if conditions like appendicitis or bowel obstruction progress without the typical pain warning signs.
Risks & severity
The severity of this condition is considered significant throughout life, though the degree of disability depends largely on protective measures and learned behaviours. Injuries accumulate over time, with childhood representing a particularly vulnerable period when exploration and play occur without natural pain-based caution. Orthopaedic complications including repeated fractures, joint destruction, and osteomyelitis are common long-term features.
Life expectancy may be reduced compared to the general population, primarily due to complications from undetected serious injuries or medical emergencies. However, with appropriate education, environmental modifications, and vigilant monitoring, many affected individuals can achieve reasonable quality of life. The condition presents from birth and persists lifelong without spontaneous improvement.
Genetic causes
Pathogenic variants in the SCN11A gene cause this form of congenital insensitivity to pain. The SCN11A gene encodes a voltage-gated sodium channel protein called Nav1.9, which plays a crucial role in the generation and transmission of pain signals within sensory neurons. These channels allow sodium ions to flow into nerve cells, creating the electrical signals that communicate pain information from injury sites to the central nervous system.
Specific variants in SCN11A can abolish the normal function of Nav1.9 channels, preventing sensory neurons from effectively transmitting pain signals even when tissue damage occurs. The nervous system's pain detection apparatus remains intact at the injury site, but the electrical relay system fails, meaning pain information never reaches conscious perception. Interestingly, different variants in the same gene can cause opposite effects - some SCN11A changes lead to pain insensitivity, whilst others cause episodic pain disorders, highlighting the channel's critical role in pain signal regulation.
Inheritance pattern
This condition follows an autosomal dominant inheritance pattern, meaning a pathogenic variant in just one copy of the SCN11A gene is sufficient to cause the disorder. Each child of an affected parent has a 50% chance of inheriting the variant and developing congenital insensitivity to pain. However, many reported cases appear to result from new (de novo) variants occurring for the first time in the affected individual, rather than being inherited from a parent.
When a variant arises de novo, the parents typically have normal pain sensation and do not carry the pathogenic change in their own genetic material. The recurrence risk for future siblings in such cases is very low, though not zero due to the possibility of parental germline mosaicism. Genetic counselling can help families understand their specific situation and recurrence risks.
Each child has a 50% chance of inheriting the pathogenic variant, regardless of sex.
Diagnosis & testing
Diagnosis typically begins with clinical recognition of pain insensitivity, often identified when an infant or young child sustains injuries without appropriate distress responses. A thorough neurological examination assesses sensory function across different modalities, distinguishing selective pain insensitivity from broader sensory neuropathies. Quantitative sensory testing may be performed in specialist centres to characterise the specific pattern of sensory loss.
Genetic testing through the NHS Genomic Medicine Service confirms the diagnosis by identifying pathogenic variants in SCN11A. Testing is typically accessed via clinical genetics services following referral from paediatric neurology or general paediatrics. The relevant NHS England R-code for genomic testing would fall under rare neurological disorders panels. Genetic confirmation not only establishes the diagnosis but also enables accurate genetic counselling regarding inheritance risks and family planning.
Management & lifestyle
Management focuses on injury prevention and early detection of complications rather than treating pain itself. A multidisciplinary approach involves paediatric neurology, orthopaedics, dentistry, and occupational therapy. Regular full-body examinations help identify injuries that have occurred without the person's awareness. Environmental modifications reduce injury risks, including temperature controls, protective equipment, and removal of sharp hazards.
Education forms a cornerstone of management, teaching affected individuals and families to recognise situations that would normally cause pain and to check regularly for signs of injury such as swelling, redness, or functional impairment. Dental care requires scheduled examinations as tooth decay and oral injuries progress silently. Physiotherapy helps maintain joint health despite the absence of pain feedback that normally limits harmful movements. Genetic counselling through the NHS provides families with information about inheritance, recurrence risks, and reproductive options.
There is currently no treatment to restore pain sensation. Research into gene therapy and other targeted approaches continues, but these remain experimental. Psychological support may benefit both affected individuals and family members adapting to the unique challenges of living without pain perception.
UK care pathway
Families concerned about congenital insensitivity to pain typically enter the care pathway through paediatric services, often following presentation with unusual injury patterns or lack of pain responses. Referral to paediatric neurology or clinical genetics services leads to comprehensive assessment and genetic testing consideration. The NHS Genomic Medicine Service provides access to diagnostic genomic testing for rare neurological conditions through appropriate test directories.
Following genetic confirmation, ongoing care is coordinated through specialist neurology services with input from multiple disciplines. Genetic counsellors within regional genetics centres offer detailed discussion of inheritance patterns, family planning options, and predictive testing for at-risk relatives. Annual or more frequent reviews monitor for complications and adjust protective strategies as the individual's environment and activities change with age.
Frequently asked questions
Can someone with congenital insensitivity to pain feel any physical sensations?
Yes, typically people with SCN11A-related pain insensitivity retain the ability to feel touch, pressure, and often temperature, though they cannot perceive pain. This means they can feel someone touching their skin but would not feel discomfort if that touch became harmful.
How do children with this condition learn to avoid injuries?
Children learn through education and observation rather than pain feedback. Parents and teachers actively teach which situations cause harm, establish regular body checks for injuries, and create safe environments. Over time, affected individuals develop cognitive strategies to replace the protective function pain normally provides.
Will my child's pain insensitivity improve as they get older?
No, the inability to feel pain persists throughout life when caused by SCN11A variants. However, many individuals develop better coping strategies with age and become more skilled at preventing injuries and recognising when something is wrong through non-pain cues like swelling or reduced function.
What should I do if I suspect my child cannot feel pain normally?
Contact your GP or paediatrician promptly if your child seems unusually unresponsive to injuries that should cause discomfort. They can arrange appropriate referrals to paediatric neurology or clinical genetics services for assessment and, if appropriate, genetic testing through the NHS Genomic Medicine Service.